About the Company
Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists developed experimental vaccines for influenza and respiratory syncytial virus (RSV), as well as Ebola and other emerging infectious diseases. During 2020, the company redirected its efforts to focus on development and approval of its NVX-CoV2373 vaccine for COVID-19. The COVID-19 vaccine Nuvaxovid was approved in the European Union at the end of 2021, and in Canada in February 2022, as the fifth vaccine against COVID-19, following Pfizer/BioNTech, Moderna, Janssen and AstraZeneca.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $NVAX News
Levi & Korsinsky, LLP Notifies Shareholders of Novavax, Inc. (NVAX) an Upcoming Claims Deadline in a Class Action Settlement
NEW YORK, NY / ACCESSWIRE / May 2, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class ...
Novavax to Cut a Quarter of Global Workforce as Covid Eases
(Bloomberg) -- Novavax Inc. shares gained the most in two years after the Covid-19 vaccine maker announced a restructuring plan that includes cutting about 25% of its global workforce. The company ...
Novavax, Inc. (NVAX)
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will participate in TD Cowen's 44th Annual Health Care Conference.
What's Going On With Novavax Stock Today?
Shah Capital appoints two new directors to the company's board. The hedge fund said it believes Novavax needs to adopt a more dynamic sales and marketing strategy, among other things. Loading..
Shah Capital calls for board shake-up at Novavax
Shah Capital, a major shareholder in Novavax, urges board shake-up citing underperformance and failure to maximize ...
Novavax gets grant for coronavirus spike proteins for stable and immunogenic vaccines
Discover how Novavax Inc's patent for coronavirus Spike proteins & nanoparticles in vaccines enhances immunogenicity & protects against SARS-CoV-2.
Levi & Korsinsky, LLP Notifies Shareholders of Novavax, Inc. (NVAX) an Upcoming Claims Deadline in a Class Action Settlement
NEW YORK, NY / ACCESSWIRE / April 18, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Novavax, Inc. (NASDAQ:NVAX).
Novavax, Inc.
What Is a Stock Market Correction? Investors may be shaken by a drop of 10% or more in a stock market index, but corrections are par for the course.
Novavax Inc.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Loading the latest forecasts...